These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 44859)

  • 21. Substance abuse and schizophrenia: effect on symptoms but not on neurocognitive function.
    Cleghorn JM; Kaplan RD; Szechtman B; Szechtman H; Brown GM; Franco S
    J Clin Psychiatry; 1991 Jan; 52(1):26-30. PubMed ID: 1671032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploration of dimensions of psychopathology in neuroleptic-naïve patients with recent-onset schizophrenia/schizophreniform disorder.
    John JP; Khanna S; Thennarasu K; Reddy S
    Psychiatry Res; 2003 Nov; 121(1):11-20. PubMed ID: 14572620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do we still believe in the dopamine hypothesis? New data bring new evidence.
    Abi-Dargham A
    Int J Neuropsychopharmacol; 2004 Mar; 7 Suppl 1():S1-5. PubMed ID: 14972078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensory gating deficits, pattern completion, and disturbed fronto-limbic balance, a model for description of hallucinations and delusions in schizophrenia.
    Javanbakht A
    Med Hypotheses; 2006; 67(5):1173-84. PubMed ID: 16824690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical diagnosis and drug therapy of elderly patients with schizophrenia : A restrospective analysis of data in a department of old age psychiatry].
    Jagsch C; Dietmaier G; Jagsch M; Kurz M
    Neuropsychiatr; 2016 Jun; 30(2):74-81. PubMed ID: 27294270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autochthonous experience, heightened awareness, and perception distortion in patients with schizophrenia: a symptomatological study.
    Honda T; Suzuki H; Iwai K; Fujiwara Y; Kawahara H; Kuroda S
    Psychiatry Clin Neurosci; 2004 Oct; 58(5):473-9. PubMed ID: 15482577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroleptics, dopamine, and schizophrenia.
    Pickar D
    Psychiatr Clin North Am; 1986 Mar; 9(1):35-48. PubMed ID: 2870480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Body dysmorphic disorder and psychosis. Case reports and discussion].
    Loréa N; Van Wijnendaele R
    Encephale; 2012 Feb; 38(1):37-41. PubMed ID: 22381722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First rank symptoms of schizophrenia: their nature and origin.
    Cutting J
    Hist Psychiatry; 2015 Jun; 26(2):131-46. PubMed ID: 26022465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Schizophrenia: an illness of distorted reality.
    Dean B
    Biologist (London); 2000 Sep; 47(4):202-6. PubMed ID: 11153121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Psychotropic drugs as tools for clinical research into schizophrenia (author's transl)].
    Beckmann H
    Fortschr Neurol Psychiatr Grenzgeb; 1978 Oct; 46(10):564-77. PubMed ID: 29831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conceptualizing schizophrenia through attenuated symptoms in the population.
    Carpenter WT
    Am J Psychiatry; 2010 Sep; 167(9):1013-6. PubMed ID: 20826849
    [No Abstract]   [Full Text] [Related]  

  • 33. [Data from a comparative study of traumatic, hallucinatory-delusional psychoses and of hallucinatory-delusional schizophrenia in persons who have experienced skull injury].
    Nikonova TB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(3):416-22. PubMed ID: 4466277
    [No Abstract]   [Full Text] [Related]  

  • 34. Syndromes of chronic schizophrenia and some clinical correlates.
    Brown KW; White T
    Br J Psychiatry; 1992 Sep; 161():317-22. PubMed ID: 1356571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The dopamine hypothesis of schizophrenia: focus on the dopamine receptor.
    Snyder SH
    Am J Psychiatry; 1976 Feb; 133(2):197-202. PubMed ID: 1251927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracellular signaling and approaches to the treatment of schizophrenia and associated cognitive impairment.
    Snyder GL; Vanover KE
    Curr Pharm Des; 2014; 20(31):5093-103. PubMed ID: 24345266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Accessory symptoms of schizophrenia: E. Bleuler's concept].
    Pyatnitskiy NY
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):114-121. PubMed ID: 29265096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First-rank symptoms of schizophrenia in Schneider-oriented German centers.
    Koehler K; Guth W; Grimm G
    Arch Gen Psychiatry; 1977 Jul; 34(7):810-3. PubMed ID: 327966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hallucinations attributed to djinns].
    Blom JD; Eker H; Basalan H; Aouaj Y; Hoek HW
    Ned Tijdschr Geneeskd; 2010; 154():A973. PubMed ID: 20132570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.